GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » Accumulated Depreciation

Lophos Holdings (XCNQ:MESC) Accumulated Depreciation : C$-0.08 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Lophos Holdings Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Lophos Holdings's quarterly accumulated depreciation increased from Sep. 2023 (C$-0.06 Mil) to Dec. 2023 (C$-0.07 Mil) and increased from Dec. 2023 (C$-0.07 Mil) to Mar. 2024 (C$-0.08 Mil).

Lophos Holdings's annual accumulated depreciation increased from Mar. 2022 (C$-0.01 Mil) to Mar. 2023 (C$-0.05 Mil) and increased from Mar. 2023 (C$-0.05 Mil) to Mar. 2024 (C$-0.08 Mil).


Lophos Holdings Accumulated Depreciation Historical Data

The historical data trend for Lophos Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lophos Holdings Accumulated Depreciation Chart

Lophos Holdings Annual Data
Trend Mar22 Mar23 Mar24
Accumulated Depreciation
-0.01 -0.05 -0.08

Lophos Holdings Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only -0.05 -0.05 -0.06 -0.07 -0.08

Lophos Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Lophos Holdings Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Lophos Holdings's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Lophos Holdings Business Description

Traded in Other Exchanges
N/A
Address
1111 Melville Street, Suite 620, Vancouver, BC, CAN, V6E 3V6
Website
Lophos Holdings Inc is engaged in the y is the cultivation of peyote and the manufacture of Lophophora compounds, including Mescaline, as well as formulation of novel Lophophora-based compounds.
Executives
John Ioannis Karagiannidis Director
Evan Stawnyczy Director

Lophos Holdings Headlines

No Headlines